Daniel L. Abravanel - Concepedia

Author

Daniel L. Abravanel

Also Known As

Alvaro Quintanal Villalonga, D.L. Abravanel, Daniel Abravanel, Daniel L Abravanel, Daniel L. Abravanel, Human Tumor Atlas Network

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Dana-Farber Cancer Institute Harvard University Broad Institute McGovern Institute for Brain Research Bar-Ilan University

About

Daniel L. Abravanel is an author at Dana-Farber Cancer Institute specializing in medicine, oncology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	432
2	Cell Biology	3	3	372
3	Engineering	1	1	76
4	Public Health	1	1	20
5	Biology	1	1	76

Daniel L. Abravanel

Publications

926

Citations

H-Index

Page 1

	Year	Citations
Expansion sequencing: Spatially precise in situ transcriptomics in intact biological systems Shahar Alon, Daniel Goodwin, Anubhav Sinha, Science	2021	392
Inhibition of γ-Secretase Activity Inhibits Tumor Progression in a Mouse Model of Pancreatic Ductal Adenocarcinoma Ruben R. Plentz, Ji–Sun Park, Andrew D. Rhim, Gastroenterology Tumor BiologyPancreatic CancerMedicinePathologyCancer Biology	2009	161
Notch promotes recurrence of dormant tumor cells following HER2/neu-targeted therapy Daniel L. Abravanel, George K. Belka, Tien-Chi Pan, Journal of Clinical Investigation Dormant Tumor CellsBreast Cancer MortalitySystems BiologyOncologyBreast Oncology	2015	135
Actomyosin purse strings: Renewable resources that make morphogenesis robust and resilient Alice Rodriguez‐Diaz, Yusuke Toyama, Daniel L. Abravanel, HFSP journal EngineeringRenewable ResourcesCytoskeletonMechanotransductionFree Edges	2008	76
A multi-modal single-cell and spatial expression map of metastatic breast cancer biopsies across clinicopathological features Johanna Klughammer, Daniel L. Abravanel, Åsa Segerstolpe, Nature Medicine	2024	50
An Acquired NRAS Q61K Mutation in BRAF V600E-Mutant Lung Adenocarcinoma Resistant to Dabrafenib Plus Trametinib Daniel L. Abravanel, Mizuki Nishino, Lynette M. Sholl, Journal of Thoracic Oncology OncologyOncogenic AgentMedicinePathologyCancer Genomics	2018	40
Expansion Sequencing: Spatially Precise <i>In Situ</i> Transcriptomics in Intact Biological Systems Shahar Alon, Daniel Goodwin, Anubhav Sinha,	2020	28
Exemestane plus everolimus and palbociclib in metastatic breast cancer: clinical response and genomic/transcriptomic determinants of resistance in a phase I/II trial Jorge Gómez Tejeda Zañudo, Romualdo Barroso‐Sousa, Esha Jain, Nature Communications	2024	24
The Metastatic Breast Cancer Project: leveraging patient-partnered research to expand the clinical and genomic landscape of metastatic breast cancer and accelerate discoveries Esha Jain, Jorge Gómez Tejeda Zañudo, Mary McGillicuddy, Preclinical TherapeuticsBreast OncologyCancer ManagementAccelerate DiscoveriesDatabases	2023	20

Page 1